Skip to content
Acurable logo — We create accurate and user friendly wearable medical device...

Acurable

We create accurate and user friendly wearable medical devices intended to be used by patients at home

Founded 2016 United Kingdom London, United Kingdom 29 employees Series A Total: $13.10M Hardware, Health Care +1

General Information

Company Name Acurable
Founded Year 2016
Location United Kingdom London, United Kingdom
Employees 29
Industries Hardware, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Acurable. To contact Acurable, visit acurable.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Acurable compare?

A PDF of Acurable and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Acurable soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Acurable

Acurable is a fast-growing, venture-backed MedTech start-up based in London and Seville. The company's focus is on creating accurate and user-friendly wearable medical devices for patients to use at home. Acurable's patented technology, developed by founder Professor Esther Rodriguez Villegas after over 10 years of research at Imperial College London, has garnered significant recognition in the industry, including awards such as the XPrize and grants from Innovate UK. The company's first product, AcuPebble SA100, received the CE mark for the automated diagnosis of obstructive sleep apnoea at home, making it the first medical device of its kind to obtain this certification. Additionally, it gained FDA clearance for home sleep apnoea testing in the US. With current utilization in healthcare organizations across the UK and Europe, and upcoming launch in the USA, Acurable is poised for further expansion. The company's ongoing research is focused on developing new products to enhance the lives of millions suffering from chronic conditions like COPD, Asthma, and Epilepsy. Last Investment: €11.00M Series A investment at 03 October 2022 Last Investment Investors: Kindred Capital, Kibo Ventures, Alma Mundi Ventures, KHP Ventures, Comprador Holdings

Business keywords: wearable medical devices, respiratory diagnostics, home healthcare, breath analysis, obstructive sleep apnoea, CE mark, FDA clearance, chronic condition management, non-invasive diagnostics

Services & Products

Development and manufacturing of wearable medical devices for home-based physiological monitoring
with a focus on sleep apnea and other chronic conditions.

Target Customers

Patients with sleep apnea epilepsy COPD asthma and other chronic conditions who require non-invasive accurate and user-friendly medical devices for home use.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series A €11.00M 5
Kindred Capital, Kibo Ventures +3
03 Oct 2022
Grant Undisclosed 1
Innovate UK
01 Oct 2022
Seed Round £2.10M 2
Kindred Capital, Alma Mundi Ventures
15 Sep 2017

Acurable Alternatives & Competitors

View All Alternatives
Acurable vs

Innovative breath-analysis devices for non-invasive management of chronic respiratory diseases throu...

Series C
1 employees
Health Care, Medical Devices
Acurable vs
ZOLL Itamar
ZOLL Itamar United States

Home Sleep Apnea Test and Digital Health Company.

Post-IPO Secondary
310 employees
Health Care, Medical Devices
Acurable vs
Biobeat
Biobeat Israel

AI remote patient monitoring platform, measuring 13 vital signs and triggering early clinical interv...

Series A
35 employees
Biotechnology, Data Analytics

FAQ About Acurable

We create accurate and user friendly wearable medical devices intended to be used by patients at home
Acurable was founded in 2016.
Acurable is headquartered in London, United Kingdom.
Acurable operates in Hardware, Health Care and Medical Devices. Its work centres on wearable medical devices, respiratory diagnostics, home healthcare and breath analysis. Its customers include Patients with sleep apnea, epilepsy and COPD.
Acurable has approximately 29 employees.
Acurable has completed 3 funding rounds, raising a total of $13.10M. The latest funding stage is Series A.
Acurable offers: Development and manufacturing of wearable medical devices for home-based physiological monitoring, with a focus on sleep apnea and other chronic conditions..
Top alternatives and competitors to Acurable include Spirometrix, Inc. (now Spirosure, Inc.), ZOLL Itamar, Biobeat, Onera Health, Inspire Medical Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Acurable and Spirometrix, Inc. (now Spirosure, Inc.) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Acurable, https://bouncewatch.com/company/acurable, updated 24 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout